Lpath, Inc.

Of the many other small-to-medium scale medtech deals in 2016, the more eye-catching were:

IN VITRO DIAGNOSTICS Mergers & Acquisitions Alere Inc. TechLab Inc. Pharos Capital Group has taken a controlling interest in TechLab Inc. from Alere Inc. and TechLab's founders Dr. Tracy Wilki

Bariatric device-maker Apollo Endosurgery Inc. and biotech company Lpath Inc. have announced plans to merge under an arrangement that will see Apollo shareholders own about 95.8% of the combin

Biogen 's license for the sphingosine 1-phosphate (S1P) receptor modulator MT-1303 from Mitsubishi Tanabe Pharma Corp. for up to $544m makes a lot of sense, but with four S1P-targeting drugs appr